DK41791A - Antibiotikum cc 1065-analoge - Google Patents

Antibiotikum cc 1065-analoge Download PDF

Info

Publication number
DK41791A
DK41791A DK041791A DK41791A DK41791A DK 41791 A DK41791 A DK 41791A DK 041791 A DK041791 A DK 041791A DK 41791 A DK41791 A DK 41791A DK 41791 A DK41791 A DK 41791A
Authority
DK
Denmark
Prior art keywords
pct
formula
date mar
compounds
sec
Prior art date
Application number
DK041791A
Other languages
English (en)
Other versions
DK41791D0 (da
DK175458B1 (da
Inventor
Paul A Aristoff
Robert C Kelly
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DK41791D0 publication Critical patent/DK41791D0/da
Publication of DK41791A publication Critical patent/DK41791A/da
Application granted granted Critical
Publication of DK175458B1 publication Critical patent/DK175458B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Error Detection And Correction (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Solid State Image Pick-Up Elements (AREA)
  • Artificial Filaments (AREA)
  • Amplifiers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Television Systems (AREA)
  • Television Receiver Circuits (AREA)
  • Stereophonic System (AREA)
DK41791A 1988-09-12 1991-03-08 Antibiotikum CC 1065-analoge DK175458B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24335088A 1988-09-12 1988-09-12
US24335088 1988-09-12
US8903329 1989-08-07
PCT/US1989/003329 WO1990002746A1 (en) 1988-09-12 1989-08-07 Novel cc-1065 analogs having two cpi subunits

Publications (3)

Publication Number Publication Date
DK41791D0 DK41791D0 (da) 1991-03-08
DK41791A true DK41791A (da) 1991-03-08
DK175458B1 DK175458B1 (da) 2004-11-01

Family

ID=22918400

Family Applications (1)

Application Number Title Priority Date Filing Date
DK41791A DK175458B1 (da) 1988-09-12 1991-03-08 Antibiotikum CC 1065-analoge

Country Status (14)

Country Link
US (1) US5541339A (da)
JP (1) JP3380237B2 (da)
KR (1) KR0137959B1 (da)
AT (1) ATE198335T1 (da)
AU (1) AU632288B2 (da)
CA (1) CA1340215C (da)
DE (1) DE68929275T2 (da)
DK (1) DK175458B1 (da)
FI (1) FI103668B (da)
GR (1) GR3035589T3 (da)
LV (1) LV12806B (da)
NO (1) NO303498B1 (da)
TW (1) TW217383B (da)
WO (1) WO1990002746A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563475B1 (en) * 1992-03-25 2000-05-31 Immunogen Inc Cell binding agent conjugates of derivatives of CC-1065
US5502068A (en) * 1995-01-31 1996-03-26 Synphar Laboratories, Inc. Cyclopropylpyrroloindole-oligopeptide anticancer agents
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
DK1392359T4 (da) 2001-05-11 2013-06-10 Ludwig Inst For Cancer Res Ltd Specifikke bindingsproteiner og deres anvendelser.
EA200400595A1 (ru) 2001-11-09 2004-10-28 Бёрингер Ингельхайм Фармасьютиклз, Инк. Бензимидазолы, применяемые в качестве ингибиторов протеинкиназы
JP2005536533A (ja) * 2002-08-08 2005-12-02 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 置換ベンゾイミダゾール化合物
JP2006505571A (ja) * 2002-10-15 2006-02-16 リゲル ファーマシューテイカルズ、インコーポレイテッド 置換されたインドール及びｈｃｖ阻害剤としてのその使用
WO2005005389A2 (en) * 2003-07-07 2005-01-20 Merck Patent Gmbh Malonamide derivatives
WO2005079791A1 (en) * 2004-02-12 2005-09-01 Boehringer Ingelheim Pharmaceuticals, Inc. Thiophene -2- carboxylic acid - (1h - benzimidazol - 2 yl) - amide derivatives and related compounds as inhibitors of the tec kinase itk (interleukin -2- inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
EP1928865A1 (en) * 2005-08-17 2008-06-11 Schering Corporation Novel high affinity thiophene-based and furan-based kinase ligands
US9090693B2 (en) 2007-01-25 2015-07-28 Dana-Farber Cancer Institute Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease
JP5618549B2 (ja) 2007-03-15 2014-11-05 ルードヴィッヒ インスティテュート フォー キャンサーリサーチ リミテッド Ｅｇｆｒ抗体及びｓｒｃ阻害剤を用いる治療方法及び関連製剤
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
JP5532486B2 (ja) 2007-08-14 2014-06-25 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ Ｅｇｆ受容体を標的とするモノクローナル抗体１７５ならびにその誘導体および用途
HUE035798T2 (en) 2008-11-03 2018-05-28 Syntarga Bv CC-1065 analogues and conjugates
NO3056203T3 (da) 2010-04-21 2018-05-12
US20150265641A1 (en) 2012-10-22 2015-09-24 Arnold Glazier Methods for the Effective Treatment of Metastatic Cancer
DE102013012622A1 (de) * 2013-07-30 2015-02-05 Clariant lnternational Ltd Neue sterisch gehinderte cyclische Amine
TR201810856T4 (tr) 2014-01-10 2018-08-27 Synthon Biopharmaceuticals Bv CYS'le bağlı antikor-ilaç konjugatlarını saflaştırmak için usul.
SG11201605437YA (en) * 2014-01-27 2016-08-30 Pfizer Bifunctional cytotoxic agents
US10973920B2 (en) 2014-06-30 2021-04-13 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
DE102015000124A1 (de) * 2015-01-07 2016-07-07 Clariant International Ltd. Verfahren zur Stabilisierung von Polyamiden
KR102046862B1 (ko) * 2015-03-20 2019-11-20 화이자 인코포레이티드 Cti 약물작용발생단을 함유하는 이관능성 세포독성제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169888A (en) * 1977-10-17 1979-10-02 The Upjohn Company Composition of matter and process
US4301248A (en) * 1979-12-21 1981-11-17 Bristol-Myers Company Fermentation process for making rachelmycin
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
GB8528848D0 (en) * 1985-11-22 1985-12-24 Davy Mckee Poole Rolling mills
AU617304B2 (en) * 1986-12-19 1991-11-28 Pharmacia & Upjohn Company Novel cc-1065 analogs

Also Published As

Publication number Publication date
FI103668B1 (fi) 1999-08-13
KR900701801A (ko) 1990-12-04
GR3035589T3 (en) 2001-06-29
DE68929275D1 (de) 2001-02-01
DE68929275T2 (de) 2001-05-23
KR0137959B1 (ko) 1998-05-15
FI911193A0 (fi) 1991-03-11
CA1340215C (en) 1998-12-15
JP3380237B2 (ja) 2003-02-24
ATE198335T1 (de) 2001-01-15
AU4192289A (en) 1990-04-02
FI103668B (fi) 1999-08-13
NO910958L (no) 1991-05-10
WO1990002746A1 (en) 1990-03-22
DK41791D0 (da) 1991-03-08
DK175458B1 (da) 2004-11-01
JPH04500664A (ja) 1992-02-06
NO910958D0 (no) 1991-03-11
US5541339A (en) 1996-07-30
LV12806A (en) 2002-03-20
TW217383B (da) 1993-12-11
AU632288B2 (en) 1992-12-24
NO303498B1 (no) 1998-07-20
LV12806B (lv) 2002-05-20

Similar Documents

Publication Publication Date Title
DK41791D0 (da) Antibiotikum cc 1065-analoge
ES2082003T3 (es) Deshidrodidemnina b.
MX9206008A (es) Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida.
BR1100989A (pt) Composto e composição de matéria
DE69130614D1 (de) Herbizide, substituierte aryl-haloalkylpyrazole
BR8606336A (pt) Derivados de pirazolina,processo para sua preparacao,composicoes inseticidas e emprego
DK0698013T3 (da) Fungicide kondenserede bicykliske pyrimidinoner
FI863836A0 (fi) Kinolinderivat.
ATE63111T1 (de) Substituierte oximether, ihre verwendung als bioregulatoren zur senkung des endogenen ethylenspiegels in pflanzen.
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
BG98238A (bg) Заместени бензотиазолови производни,получаванетоим и приложението им като хербициди
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
DE69003050D1 (de) S-substituierte beta-Thioacrylamide und deren Verwendung als Mikrobizide.
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2037597B1 (es) Perfeccionamientos en o relacionados con compuestos organicos.
DE3772909D1 (de) 3-methylphthalimide.
MX9201809A (es) N-hidroxi-n-(3-(fenil 2 substituido)prop-2-enil)urea y tiourea y formulacion farmaceutica que las contiene.
DE59809344D1 (de) Disubstituierte biphenyloxazoline
ES2055700T3 (es) Mezclas bactericidas.
BR9911522A (pt) Composição artropodicida e método de controle de artrópodes em ambientes não agronÈmicos e em ambientes da saúde animal
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
ATE87314T1 (de) Platin-arzneimittel.
DE3660426D1 (de) Urea acryl derivatives
ATE3751T1 (de) Wasserloesliche polyester und polycarbonate zur verwendung als antitumorwirkstoffe.
ATE82980T1 (de) (gem-heterocyclodimethanamin-n,n')platin komplexe.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK